Nevoid basal cell carcinoma syndrome (Gorlin syndrome)
Open Access
- 25 November 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 3 (1), 32
- https://doi.org/10.1186/1750-1172-3-32
Abstract
Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a hereditary condition characterized by a wide range of developmental abnormalities and a predisposition to neoplasms.Keywords
This publication has 149 references indexed in Scilit:
- Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laserJournal of the American Academy of Dermatology, 2006
- PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French studyBritish Journal of Cancer, 2006
- Meningiomas after medulloblastoma irradiation treatment in a patient with basal cell nevus syndromeJournal of the American Academy of Dermatology, 2005
- Molecular characterization of Italian nevoid basal cell carcinoma syndrome patientsHuman Mutation, 2005
- Spectrum of PTCH1 Mutations in French Patients with Gorlin SyndromeJournal of Investigative Dermatology, 2003
- Nevoid basal cell carcinoma syndrome: Relation with desmoplastic medulloblastoma in infancyCancer, 2003
- Treatment and prevention of basal cell carcinoma with oral isotretinoinJournal of the American Academy of Dermatology, 1988
- Case 10-1986The New England Journal of Medicine, 1986
- Chemoprevention of basal cell carcinoma with isotretinoinJournal of the American Academy of Dermatology, 1982
- Neurological involvement in the nevoid basal cell carcinoma syndromeJournal of Neurosurgery, 1971